Recommendations to Address the Unique Clinical and Psychological Needs of Transgender Persons Living With Multiple Sclerosis

Overview

Journal Int J MS Care

Date 2022 Mar 9

PMID 35261570

Authors

Amy Sullivan

Alexa Kane

Gianna Valentic

Mary Rensel

Affiliations

Soon will be listed here.

Abstract

Background: People living with multiple sclerosis (MS) face challenges coping with chronic illnesses, and transgender (TGD) persons living with MS may experience additional unique challenges and barriers to care. Medical biases toward TGD people are widely reported, and best practices in TGD MS care have not been identified.

Methods: A case report of a TGD person living with MS is reviewed that helped to identify and inform us regarding the unique aspects of their clinical and psychological care needs. We conducted a systematic review of the literature according to the standard methods in PubMed. The literature was reviewed and summarized for relevant topics related to the unique care needs of TGD persons living with MS, and proposed care recommendations were created.

Results: We used the aforementioned case to identify and inform the special care needs and subsequently describe proposed recommendations to achieve inclusive comprehensive care of TGD persons with MS. The importance of providing an inclusive environment, comprehensive care, mental health screening, domestic violence screening, and case coordination are highlighted with the goal of providing best practice recommendations for the comprehensive inclusive care of TGD persons living with MS.

Conclusions: The lack of published guidance on the care of TGD persons living with MS and our informative case have led to the proposed recommendations for the care of TGD persons living with MS.

Citing Articles

Hormonal Therapies in Multiple Sclerosis: a Review of Clinical Data.

Hsu S, Bove R Curr Neurol Neurosci Rep. 2023; 24(1):1-15.

PMID: 38102502 PMC: 10774191. DOI: 10.1007/s11910-023-01326-7.

Podcast on the Challenges and Recommendations to Address Unmet Needs in MS for LGBTQ+ Populations in the United States.

Conte W, Cascione M, Sullivan A Neurol Ther. 2023; 12(5):1399-1407.

PMID: 37353720 PMC: 10444714. DOI: 10.1007/s40120-023-00506-4.

Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: How it influences clinical course, MRI parameters and prognosis.

Nytrova P, Dolezal O Front Immunol. 2022; 13:933415.

PMID: 36016923 PMC: 9396644. DOI: 10.3389/fimmu.2022.933415.

References

Houssayni S, Nilsen K . Transgender Competent Provider: Identifying Transgender Health Needs, Health Disparities, and Health Coverage. Kans J Med. 2018; 11(1):1-18. PMC: 5834239. View

Renukanthan A, Quinton R, Turner B, MacCallum P, Seal L, Davies A . Kallmann syndrome patient with gender dysphoria, multiple sclerosis, and thrombophilia. Endocrine. 2015; 50(2):496-503. DOI: 10.1007/s12020-015-0562-5. View

Lavorgna L, Moccia M, Russo A, Palladino R, Riccio L, Lanzillo R . Health-care disparities stemming from sexual orientation of Italian patients with Multiple Sclerosis: A cross-sectional web-based study. Mult Scler Relat Disord. 2017; 13:28-32. DOI: 10.1016/j.msard.2017.02.001. View

Van Donge N, Schvey N, Roberts T, Klein D . Transgender Dependent Adolescents in the U.S. Military Health Care System: Demographics, Treatments Sought, and Health Care Service Utilization. Mil Med. 2018; 184(5-6):e447-e454. DOI: 10.1093/milmed/usy264. View

Feldman J, Brown G, Deutsch M, Hembree W, Meyer W, Meyer-Bahlburg H . Priorities for transgender medical and healthcare research. Curr Opin Endocrinol Diabetes Obes. 2016; 23(2):180-7. PMC: 4821501. DOI: 10.1097/MED.0000000000000231. View

Khayambashi S, Salter A, Tyry T, Cutter G, Fox R, Marrie R . Gender identity and sexual orientation affect health care satisfaction, but not utilization, in persons with Multiple Sclerosis. Mult Scler Relat Disord. 2020; 37:101440. DOI: 10.1016/j.msard.2019.101440. View

Safer J, Coleman E, Feldman J, Garofalo R, Hembree W, Radix A . Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes. 2016; 23(2):168-71. PMC: 4802845. DOI: 10.1097/MED.0000000000000227. View

Nathoo N, Mackie A . Treating depression in multiple sclerosis with antidepressants: A brief review of clinical trials and exploration of clinical symptoms to guide treatment decisions. Mult Scler Relat Disord. 2017; 18:177-180. DOI: 10.1016/j.msard.2017.10.004. View

Shumer D, Nokoff N, Spack N . Advances in the Care of Transgender Children and Adolescents. Adv Pediatr. 2016; 63(1):79-102. PMC: 4955762. DOI: 10.1016/j.yapd.2016.04.018. View

10.

Gilli F, DiSano K, Pachner A . SeXX Matters in Multiple Sclerosis. Front Neurol. 2020; 11:616. PMC: 7347971. DOI: 10.3389/fneur.2020.00616. View

11.

Nikkels C, Trotsenburg M, Huirne J, Bouman M, de Leeuw R, Van Mello N . Vaginal Colpectomy in Transgender Men: A Retrospective Cohort Study on Surgical Procedure and Outcomes. J Sex Med. 2019; 16(6):924-933. DOI: 10.1016/j.jsxm.2019.03.263. View

12.

de Vries A, Steensma T, Doreleijers T, Cohen-Kettenis P . Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study. J Sex Med. 2010; 8(8):2276-83. DOI: 10.1111/j.1743-6109.2010.01943.x. View

13.

Stroumsa D, Wu J . Welcoming transgender and nonbinary patients: expanding the language of "women's health". Am J Obstet Gynecol. 2018; 219(6):585.e1-585.e5. DOI: 10.1016/j.ajog.2018.09.018. View

14.

Karim H, Kim S, Lauderdale K, Lapato A, Atkinson K, Yasui N . Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis. Sci Rep. 2019; 9(1):503. PMC: 6345788. DOI: 10.1038/s41598-018-37420-x. View

15.

Kranz G, Hahn A, Kaufmann U, Tik M, Ganger S, Seiger R . Effects of testosterone treatment on hypothalamic neuroplasticity in female-to-male transgender individuals. Brain Struct Funct. 2017; 223(1):321-328. PMC: 5772168. DOI: 10.1007/s00429-017-1494-z. View

16.

Baecher-Allan C, Kaskow B, Weiner H . Multiple Sclerosis: Mechanisms and Immunotherapy. Neuron. 2018; 97(4):742-768. DOI: 10.1016/j.neuron.2018.01.021. View

17.

Zubiaurre-Elorza L, Junque C, Gomez-Gil E, Guillamon A . Effects of cross-sex hormone treatment on cortical thickness in transsexual individuals. J Sex Med. 2014; 11(5):1248-61. DOI: 10.1111/jsm.12491. View

18.

Nguyen H, Loughead J, Lipner E, Hantsoo L, Kornfield S, Epperson C . What has sex got to do with it? The role of hormones in the transgender brain. Neuropsychopharmacology. 2018; 44(1):22-37. PMC: 6235900. DOI: 10.1038/s41386-018-0140-7. View

19.

Thompson A, Banwell B, Barkhof F, Carroll W, Coetzee T, Comi G . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017; 17(2):162-173. DOI: 10.1016/S1474-4422(17)30470-2. View

20.

Dubin S, Nolan I, Streed Jr C, Greene R, Radix A, Morrison S . Transgender health care: improving medical students' and residents' training and awareness. Adv Med Educ Pract. 2018; 9:377-391. PMC: 5967378. DOI: 10.2147/AMEP.S147183. View